Tata Capital Shares Rise 5% After Q2, Analysts Flag Margin Revival

Tata Capital’s Earnings Beat Puts Funding Costs in Focus

Profit growth and expanding assets supported the rally, but a fourth consecutive quarterly decline in margins leaves the recovery dependent on pricing and product mix.

A strong profit figure, with a more measured income signal

Tata Capital reported consolidated net profit of ₹1,660 crore for the September quarter of FY27, up 51% from ₹1,097 crore a year earlier. Its shares climbed to an intraday high of ₹315.65 on the BSE, compared with the previous close of ₹300.80. More than 5 million shares changed hands across the BSE and NSE combined, while the broader market was weaker: at 11.50 am, the stock was up 3% and the Sensex was down 0.80%.

The headline profit growth was accompanied by 26% growth in assets under management (AUM), but net interest income (NII) rose 23% to ₹3,700 crore. That gap is worth watching: expansion in the loan book does not automatically translate into proportionate income growth when the yield earned on assets and the cost of funding are moving in different directions.

Funding costs extend the margin squeeze

Net interest margin (NIM) fell by 9 basis points quarter-on-quarter to about 4.9%, marking the fourth straight quarterly decline. The company’s calculated cost of funds rose 13 basis points, driven by EBLR- and repo-linked bank borrowings. The increase was sharper than the 6–7 basis-point rise reported for large peers, according to the supplied analysis.

For a lender, the spread between income from loans and funding costs is a key determinant of how effectively balance-sheet growth converts into earnings. Continued AUM expansion can support revenue, but persistent margin compression may temper that benefit. The quarter therefore shifts attention from growth alone to whether pricing and a richer product mix can help restore margins.

Guidance holds; a turnaround is not yet in the numbers

Management retained its medium-term AUM growth guidance of 23–25%. It expects NIM plus fees to remain stable or improve marginally in the third quarter, followed by a stronger recovery in the fourth quarter of FY27. The stated drivers are pricing actions and an improving product mix. These expectations provide a path to recovery, but the reported quarter itself still showed falling NIM.

The distinction matters for investors assessing earnings momentum. A recovery depends on the company’s ability to pass through pricing changes and increase the contribution from higher-margin assets, while continuing to grow AUM. The next results will help show whether those levers are beginning to offset the pressure from borrowing costs.

Brokerages split on how much upside remains

JM Financial maintained a ‘BUY’ rating and a ₹400 target price, identifying a NIM turnaround as the key trigger for earnings upgrades. Its view is that the recovery could follow as PLR hikes flow through and higher-margin AUM growth catches up with disbursals. The brokerage values the company at 2.8 times estimated FY28 book value per share, alongside its stated average return-on-assets and return-on-equity estimates for FY27–29.

Motilal Oswal Financial Services, by contrast, kept a ‘NEUTRAL’ rating with a ₹340 target price. It described the outlook as favourable but said current valuations already reflect near-term growth and earnings potential. The divergence underscores the central debate: whether margin improvement can deliver further earnings upside or is already substantially priced in.

Key Highlights

• Tata Capital’s consolidated net profit rose 51% year-on-year to ₹1,660 crore.
• AUM grew 26%, while NII increased 23% to ₹3,700 crore.
• NIM declined 9 basis points quarter-on-quarter to about 4.9%, its fourth consecutive quarterly fall.
• Management retained AUM growth guidance of 23–25% and expects a stronger margin recovery in Q4 FY27.
• JM Financial maintained ‘BUY’ with a ₹400 target; Motilal Oswal retained ‘NEUTRAL’ with a ₹340 target.

Investor Note: The earnings growth and AUM expansion are constructive, but the margin trend remains the key test. Investors may wish to track whether pricing actions and product mix improve NIM, while weighing the differing brokerage views and their own assessment of valuation and risk.